NSEOutcome of Board Meeting16h ago · 3 Sept 2026, 02:46 pm
Outcome of Board Meeting
Fischer Medical Ventures Limited · FISCHER
✦ AI SummaryMgmt Change
Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026, where the Board of Directors approved and took on record the appointment of Mr. David Yeow as the Additional Independent Director and reconstitution of the Audit Committee.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.
Attachments (1)
📄pdf
Download →
FISCHER_03092026144605_Bmoutcome.pdf
View document text
FISCHER MEDICAL VENTURES LIMITED
(Formerly known as Fischer Chemic Limited)
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
September 3, 2026
BSE Limited National Stock Exchange of India Ltd.
Corporate Relationship Department Exchange Plaza, 5tll floor
25th Floor, P J Towers Plot No. C/ 1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex Bandra (E),
Mumbai – 400 001. Mumbai - 400 051.
BSE Scrip Code: 524743 NSE Symbol: FISCHER
Dear Sir/ Madam,
Sub: Outcome of Board Meeting held on 3rd September, 2026
Pursuant to Regulation 30 & 33 read with Para A of Part A of Schedule III of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have inter-alia
approved and taken on record the following at its meeting held today (03/09/2026):
Appointment of Independent Director:
Approved the appointment of Mr. David Yeow as the Additional Independent Director (DIN:
11923054) with effect from 3rd September 2026. Details as required under Regulation 30 of the SEBI
(LODR) Regulations, 2015 are enclosed herewith as Annexure-1.
Reconstitution of Audit Committee:
Pursuant to appointment of Independent Director, the Board has approved the reconstitution of the
Audit Committee of the Board. Details as required under Regulation30 of the SEBI (LODR)
Regulations, 2015 are enclosed herewith as Annexure 2.
33rd Annual General Meeting:
The 33rd Annual General Meeting ('AGM') of the Members of the Company will be held on Tuesday,
29th September 2026 through video conferencing or other audio-visual means at 11.00 AM IST.
Considered & approved the appointment of M/s Nuren Lodaya & Associates Practicing Company
Secretary, Mumbai as Scrutinizer of the Annual General Meeting, to scrutinize the e-voting and remote
e-voting process in a fair and transparent manner.
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
FISCHER MEDICAL VENTURES LIMITED
(Formerly known as Fischer Chemic Limited)
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
Closure of Register of Members:
Please note that the share transfer books of the Company will remain closed 23/09/2026 (Wednesday)
to 29/09/2026 (Tuesday) (both days inclusive).
The Board Meeting commenced at 11:15 AM (IST) and concluded at 02:20 PM (IST)
Please take on record.
Thanking You,
Yours Truly,
FoFor FISCHER MEDICAL VENTURES LIMITED
BALAJI GANDLA
COMPANY SECRETARY AND COMPLIANCE OFFICER
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
FISCHER MEDICAL VENTURES LIMITED
(Formerly known as Fischer Chemic Limited)
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
ANNEXURE – 1
Details under Regulation 30 of the Listing Regulations read with SEBI Circular No. EBI/HO/CFD/CFD-
PoD-1/P/CIR/2023/123 dated July 13, 2023.
Name MR. DAVID YEOW
DIN 11923054
Reason for change viz. Appointment of Mr. David Yeow (DIN: 11923054), as an Additional Non-
appointment, Executive Independent Director of the Company
reappointment, resignation,
removal, death or otherwise
Date of appointment/re- Appointment of Mr. David Yeow (DIN: 11923054), as an Additional Non-
appointment/cessation (as Executive Independent Director of the Company, not liable to retire by rotation,
applicable) & term of for a first term of five consecutive years effective from September 3, 2026,
appointment/reappointment subject to the approval of Shareholders.
Term of 5 years
appointment/reappointment;
Brief profile (in case of Mr. David Yeow, is an accomplished engineer from Singapore, is business
appointment) leader and technology commercialisation professional with over three decades
of experience across manufacturing, quality systems, global supply chain
management, technology transfer and innovation.
He holds a Diplôme d’Ingénieur (equivalent to M.Eng.) in Electronic
Engineering from the École Nationale Supérieure d'Électronique et de
Radioélectricité de Bordeaux, France, and is a GE-certified Six Sigma
Blackbelt.
He has held senior leadership positions with GE Plastics, Lanxess and
NTUitive, where he led technology assessment, commercialisation and
technology transfer initiatives. He currently serves as Principal at Hunniwell
Lake Ventures, a medical device venture capital firm. He has also served on the
boards of several technology-driven companies.
Disclosure of relationships Mr. David Yeow is not related to any other Director of the Company.
between Directors
Information as required Mr. David Yeow is not debarred from holding the office of Director by virtue
pursuant to BSE Circular of any SEBI Order or any such authority.
ref. no.
LIST/COMP/14/2018-19 and
NSE ref. no.
NSE/ML/2018/24 dated June
20, 2018.
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
FISCHER MEDICAL VENTURES LIMITED
(Formerly known as Fischer Chemic Limited)
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
ANNEXURE-2
Audit Committee:
S no Name of the Director Status Category
1 Mr. Khairy Jamaluddin Abu Bakar Chairman Independent Director
2 Ms. Jaya Ankur Singhania Member Independent Director
3 Mr. Chan Sing En Member Independent Director
4 Dr. Syed Jalaludin Member Independent Director
5 Mr. Ravindran Govindan Member Executive Director
6 Ms. Svetlana Rao Raviwada Member Whole Time Director
7 Mr. David Yeow Member Independent Director
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006